The US Food & Drug Administration's recent approval of Biogen's Alzheimer drug, Aduhelm, has sparked debate and controversy over how to measure the efficacy of medications against psychiatric and neurological disorders.
Lundbeck is acutely aware of this. The pharmaceutical company has previously experienced many setbacks in mid and late phase trials after preclininical and early clinical trials showed promising results.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
CHMP recommends nine new drugs, rejects one
Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.
WS Audiology still chewing over listing of online hearing company
The hearing giant is still mulling over the independent listing of Hear.com.
CEO at WSA: No clarity on EQT exit plans yet
The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.
Oticon: Covid-19 led to debates about product launches
The unpredictable world situation in the spring of 2020 meant that the timing of product launches was frequently discussed at Demant-owned Oticon, located in Denmark.
EU Commission ends Danish HERA dreams – but could provide new opportunities for the pharmaceutical industry
With a budget potentially exceeding EUR 47.1bn (DKK 350bn), the EU Commission wants to establish a new agency to ward against future health crises. While the financial makeup is uncertain, good news for future clinical trials might be on the way.
Senior Downstream Scientist - Symphogen 
CMC Senior Project Manager - Genmab 
Development Laboratory Manager - Pharmaceutical Product Development - Orifarm 
Senior Clinical Research Specialist - Ambu 
Evaxion Biotech Careers 
Senior Project Leader - Vaccibody 
Senior Drug Product Specialist - Zealand Pharma 
Principal Scientist, Protein Drug Discovery & Development - Y-mAbs Therapeutics A/S 
KLIFO is looking for a talented Medical Writer (DK, SE or DE) 
Project Manager, Adcendo ApS 
Employee of the regulatory department with knowledge of food safety and legislation within dietary supplements and medicines